Immunome Inc (IMNM) — Financial Flexibility Index
Immunome Inc (IMNM) has a Financial Flexibility Index of -0.90x as of December 2025. Free cash flow of $-43.95 Million (operating CF $-47.95 Million minus capex $4.00 Million) represents -1% of total liabilities ($48.84 Million). Check Immunome Inc (IMNM) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immunome Inc Financial Flexibility Index (2018–2025)
Historical Financial Flexibility Index trend for Immunome Inc across 8 annual periods. See IMNM net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Immunome Inc (2018–2025)
Year-by-year free cash flow to debt coverage for Immunome Inc. For the full company profile including market capitalisation, see Immunome Inc (IMNM) market capitalisation.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -3.71x | $-181.23 Million | $-190.92 Million | $48.84 Million | ▼ -282.6% |
| 2024 | -0.97x | $-57.29 Million | $-110.79 Million | $59.08 Million | ▼ -312.5% |
| 2023 | -0.24x | $-6.74 Million | $-7.57 Million | $28.66 Million | ▲ +93.9% |
| 2022 | -3.85x | $-28.44 Million | $-28.69 Million | $7.39 Million | ▼ -106.5% |
| 2021 | -1.86x | $-18.15 Million | $-18.23 Million | $9.74 Million | ▲ +48.7% |
| 2020 | -3.63x | $-11.55 Million | $-12.13 Million | $3.18 Million | ▼ -1477.5% |
| 2019 | -0.23x | $-9.37 Million | $-9.60 Million | $40.69 Million | ▲ +4.9% |
| 2018 | -0.24x | $-7.18 Million | $-7.41 Million | $29.65 Million | — |